DUSP2 | Dual specificity phosphatase 2 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
E2F1 | E2F transcription factor 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
E2F2 | E2F transcription factor 2 | Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
EBLN2 | Endogenous Bornavirus-like nucleoprotein 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
FAM46A | Family with sequence similarity 46, member A | Predicted intracellular proteins
| | | | | Tissue enhanced |
FBXO5 | F-box protein 5 | Predicted intracellular proteins
| | | | | Tissue enhanced |
FFAR1 | Free fatty acid receptor 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
FFAR2 | Free fatty acid receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
FGFBP2 | Fibroblast growth factor binding protein 2 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FPR1 | Formyl peptide receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GCH1 | GTP cyclohydrolase 1 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
GFI1 | Growth factor independent 1 transcription repressor | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
GJB6 | Gap junction protein, beta 6, 30kDa | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
GLT1D1 | Glycosyltransferase 1 domain containing 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
GNA15 | Guanine nucleotide binding protein (G protein), alpha 15 (Gq class) | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
GNLY | Granulysin | Predicted intracellular proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
GP9 | Glycoprotein IX (platelet) | CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
GPR141 | G protein-coupled receptor 141 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GPR84 | G protein-coupled receptor 84 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GYPE | Glycophorin E (MNS blood group) | Predicted membrane proteins
| | | | | Tissue enhanced |
HBZ | Hemoglobin, zeta | Predicted intracellular proteins
| | | | | Tissue enhanced |
HCAR3 | Hydroxycarboxylic acid receptor 3 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
HIST1H2AB | Histone cluster 1, H2ab | Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H2AD | Histone cluster 1, H2ad | Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H2AI | Histone cluster 1, H2ai | Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H2AJ | Histone cluster 1, H2aj | Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H2AM | Histone cluster 1, H2am | Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H2BE | Histone cluster 1, H2be | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H2BI | Histone cluster 1, H2bi | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H2BM | Histone cluster 1, H2bm | Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H2BO | Histone cluster 1, H2bo | Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H3C | Histone cluster 1, H3c | Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H3D | Histone cluster 1, H3d | Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H3F | Histone cluster 1, H3f | Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H3I | Histone cluster 1, H3i | Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H3J | Histone cluster 1, H3j | Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H4A | Histone cluster 1, H4a | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H4B | Histone cluster 1, H4b | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H4F | Histone cluster 1, H4f | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H4J | Histone cluster 1, H4j | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST2H2AB | Histone cluster 2, H2ab | Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST2H2AC | Histone cluster 2, H2ac | Predicted intracellular proteins
| | | | | Tissue enhanced |
HJURP | Holliday junction recognition protein | Predicted intracellular proteins
| | | | | Tissue enhanced |
HK3 | Hexokinase 3 (white cell) | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
HMGA2 | High mobility group AT-hook 2 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
HMHB1 | Histocompatibility (minor) HB-1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
HRH2 | Histamine receptor H2 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ICAM4 | Intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) | Blood group antigen proteins CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IFNG | Interferon, gamma | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IL18RAP | Interleukin 18 receptor accessory protein | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |